Skip to main content
. 2018 Jul 12;5:92. doi: 10.3389/fcvm.2018.00092

Figure 1.

Figure 1

Evolution of operative risk in major trials. Decline in operative risk, as assessed by the STS-PROM score, in major randomized trials comparing TAVI and SAVR (610) and anticipated low to intermediate risk of currently active trials (CoreValve LR, DEDICATE, NOTION 2, PARTNER 3). SAVR, surgical aortic valve replacement; STS-PROM, Society of Thoracic Surgeons' Predicted Risk of Operative Mortality; TAVI, transcatheter aortic valve implantation.